Personalized Medicine

Improving the selection of drug treatment for individual cancer patients is of high importance. Increasing numbers of treatments options in the clinic, and fast expanding numbers of new drugs in clinical development urge implementation of novel technologies. 

VitroScans’ best-in-class technology is based on testing drug sensitivity on ex vivo 3D tumor cultures from patients. Our Drug Response Platform is proven effective for identification and testing (new) drugs for cancer treatment, it is scalable, and very suitable for accurate testing of large number of patients’ samples.